Table 2 Association between the ApoB/ApoA-Ι ratio and MACE and readmission occurrence during the follow-up period.
End point | Category | Crude model | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|---|
HR(95%CI) | P value | HR(95%CI) | P value | HR(95%CI) | P value | ||
MACEs | ApoB/ApoA-Ι | 1.60 (1.13–2.27) | 0.007 | 1.65 (1.17–2.34) | 0.005 | 3.13 (1.92–5.12) | < 0.001 |
Low ratio | 1.0 (Reference) | 1.0 (Reference) | 1.0 (Reference) | ||||
High ratio | 1.29 (1.01–1.65) | 0.038 | 1.31 (1.03–1.67) | 0.030 | 1.54 (1.14–2.09) | 0.005 | |
Readmission | ApoB/ApoA-Ι | 1.43 (1.03–1.98) | 0.034 | 1.49 (1.07–2.08) | 0.018 | 2.40 (1.49–3.87) | < 0.001 |
Low ratio | 1.0 (Reference) | 1.0 (Reference) | 1.0 (Reference) | ||||
High ratio | 1.23 (0.99–1.54) | 0.065 | 1.26 (1.01–1.57) | 0.045 | 1.43 (1.08–1.88) | 0.012 | |